NEU 0.35% $19.97 neuren pharmaceuticals limited

Ann: Plans for Phase 3 trial in Rett syndrome

  1. lightbulb Created with Sketch. 851
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.